Clinical trials: Fucoxanthin

Metabolic Syndrome

Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion

• Completed
• Age: 30 to 60 years
• Phase 2
• Results posted

The Metabolic Syndrome (MS) is a cluster of cardiometabolic risk factors, which include abdominal obesity, hyperglycemia, dyslipidemia, and high blood pressure.

Trial name

NCT03613740

Testing

Fucoxanthin

Where

Mexico

Volunteers

28 people

Sponsor

University of Guadalajara